105 related articles for article (PubMed ID: 24023342)
1. E6/E7 mRNA expression of high-risk HPV types in 849 Greek women.
Argyri E; Tsimplaki E; Daskalopoulou D; Stravopodis DJ; Kouikoglou O; Terzakis E; Panotopoulou E
Anticancer Res; 2013 Sep; 33(9):4007-11. PubMed ID: 24023342
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.
Salimović-Bešić I; Tomić-Čiča A; Smailji A; Hukić M
J Virol Methods; 2013 Dec; 194(1-2):222-8. PubMed ID: 24036071
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
6. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.
Molden T; Kraus I; Karlsen F; Skomedal H; Hagmar B
Gynecol Oncol; 2006 Jan; 100(1):95-100. PubMed ID: 16153696
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
9. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
10. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
[TBL] [Abstract][Full Text] [Related]
11. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.
Cattani P; Siddu A; D'Onghia S; Marchetti S; Santangelo R; Vellone VG; Zannoni GF; Fadda G
J Clin Microbiol; 2009 Jul; 47(7):2136-41. PubMed ID: 19403762
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
13. [Clinical research of HPV DNA detection and HPV RNA detection in single time].
Lu WB; Jiang ZN; Chen SM; Qin SR; Zhao LJ; Yang HT; Shi DH; Chen XM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):378-80. PubMed ID: 20387492
[TBL] [Abstract][Full Text] [Related]
14. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
Ardiç N; Oztürk O; Ergünay K; Sezer O
Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
[TBL] [Abstract][Full Text] [Related]
16. [Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes].
Doganov A; Kostova P; Boyanova M; Velcheva D; Tchoncheva V; Mainhard K; Zlatkov V
Akush Ginekol (Sofiia); 2012; 51(3):22-4. PubMed ID: 23236661
[TBL] [Abstract][Full Text] [Related]
17. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
19. Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Rong S; Okunieff P; Zhang L; Li X
J Virol Methods; 2015 Nov; 224():35-41. PubMed ID: 26297960
[TBL] [Abstract][Full Text] [Related]
20. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
Shen Y; Gong J; He Y; Cheng G; Okunieff P; Li X
J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
